Article
Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
2021-03-22
Abstract excerpt
Abstract: Oncogenic RAS mutations drive more than half of human cancers, and RAS inhibition is the holy grail of oncology. Thirty years of relentless efforts and harsh disappointments have taught us about the intricacies of oncogenic RAS signalling that allow us to now get a pharmacological grip on this elusive protein. The inhibition of effector pathways, such as the RAF-MEK-ERK pathway, has largely proven disapp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f2633394-a57b-5a24-b0db-2b946cf74562
- DOI
- 10.20944/preprints202103.0510.v1
